From: Study of T Cell subsets and IL-7 protein expression in HIV-1-infected patients after 7 years HAART
 | Effective Group | Ineffective Group | Untreated Group | Control Group |
---|---|---|---|---|
Number of Subjects | 25 | 18 | 17 | 15 |
Sex | Â | Â | Â | Â |
   Male | 19(76%) | 13(72.2%) | 13(76.5%) | 9(60%) |
   Female | 6(24%) | 5(27.8%) | 4(23.5%) | 6(40%) |
Age | 47.6 ± 9.1 | 45.7 ± 10.4 | 39.7 ± 11.3 | 40.5 ± 9.7 |
 | (35~71) | (31~60) | (36~63) | (33~57) |
Transmission | Â | Â | Â | Â |
   Sexual | 21(84%) | 16(88.8%) | 16(94.1%) | -- |
   Blood | 3(12%) | 1(5.6%) | 1(5.9%) | -- |
   Other | 1(4%) | 1(5.6%) | 0 | -- |
CD4+ T (cells/[μL) * | 187 | 175 | 341 | 736 |
 | (22~367) | (56~341) | (78~400) | (452~1038) |
   < 200 | 13(52%) | 10(55.6%) | 2(11.8%) | 0 |
   ≥ 200~ < 350 | 11(44%) | 8(44.4%) | 5(29.4%) | 0 |
   ≥ 350 | 1(4%) | 0 | 10(58.8%) | 15(100%) |
Therapy | Â | Â | Â | Â |
   2NRTIs+NNRTI | 13(52%) | 11(61.1%) | -- | -- |
   2NRTIs+PI | 12(48%) | 7(38.9%) | -- | -- |